AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24585907 — intervention group
Group type: COMPARATOR
Intervention: Hand-sewn technique
Number of subjects: 53
Study 22918614 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosphenytoin sodium 22.5 mg/kg at an infusion rate of 3 mg/kg/min
Number of subjects: 0
Study 22918614 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosphenytoin sodium 30 mg/kg
Number of subjects: 0
Study 21358898 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger Incentive (LI) - $100 maximum incentive
Number of subjects: 57
Study 21358898 — intervention group
Group type: COMPARATOR
Intervention: Smaller Incentive (SI) - $32 maximum incentive
Number of subjects: 57
Study 21358898 — intervention group
Group type: EXPERIMENTAL
Intervention: Descending payment schedule
Number of subjects: 57
Study 21358898 — intervention group
Group type: EXPERIMENTAL
Intervention: Escalating payment schedule
Number of subjects: 57
Study 21358898 — intervention group
Group type: EXPERIMENTAL
Intervention: Descending groups during first five visits
Number of subjects: 57
Study 18081602 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Burch colposuspension
Number of subjects: 72
Study 18081602 — intervention group
Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 72
Study 18081602 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study 15721694 — intervention group
Group type: EXPERIMENTAL
Intervention: Photorefractive keratectomy (PRK) with Technolas 217C excimer laser
Number of subjects: 70
Study 12214891 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (sal)
Number of subjects: 44
Study 12214891 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium (ipra)
Number of subjects: 44
Study 12214891 — intervention group
Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 44
Study 10542894 — intervention group
Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 9324
Study 10542894 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 9324
Study 8907587 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (25 mg, single oral dose)
Number of subjects: 0
Study 8907587 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental compounds (CGP-28238, Dup-697, NS-398, SC-58125, L-745,337)
Number of subjects: 0
Study 8907587 — intervention group
Group type: COMPARATOR
Intervention: LPS (100 mu g/mL)
Number of subjects: 0
Study 8907587 — intervention group
Group type: COMPARATOR
Intervention: PBS
Number of subjects: 0
Study 1760907 — intervention group
Group type: EXPERIMENTAL
Intervention: Barium meal
Number of subjects: 64
Study 1760907 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper gastrointestinal endoscopy
Number of subjects: 64
Study 1760907 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopy with mild sedation
Number of subjects: 64
Study 1760907 — intervention group
Group type: COMPARATOR
Intervention: Clinical diagnosis
Number of subjects: 64
Study 1760907 — intervention group
Group type: COMPARATOR
Intervention: Management change
Number of subjects: 64
Study 6755682 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressimmune (AHLG‐Behring) at 30 mg/kg/bdw for 21 days
Number of subjects: 60
Study 6755682 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 30554828 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabiximols (oromucosal spray containing 2.7 mg delta-9-tetrahydrocannabinol and 2.5 mg cannabidiol, self-titrated up to 12 actuations per 24 h for 6 weeks)
Number of subjects: 60
Study 30554828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30554828 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabiximols
Number of subjects: 60
Study 28421384 — intervention group
Group type: EXPERIMENTAL
Intervention: Guolin-Qigong (GLQG)
Number of subjects: 158
Study 28421384 — intervention group
Group type: COMPARATOR
Intervention: Physical stretching program (control group)
Number of subjects: 158
Study 26031321 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixture of PAHs (phenanthrene, fluoranthene, benzo(a)pyrene)
Number of subjects: 0
Study 26031321 — intervention group
Group type: COMPARATOR
Intervention: Single contaminants (phenanthrene, fluoranthene, benzo(a)pyrene)
Number of subjects: 0
Study 26031321 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of PAHs (single compounds or mixtures)
Number of subjects: 0
Study 25100138 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (5 mL/s and 90 mAs)
Number of subjects: 119
Study 25100138 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (3.5 mL/s and 135 mAs)
Number of subjects: 119
Study 25100138 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (5 mL/s and 135 mAs)
Number of subjects: 119
Study 25100138 — intervention group
Group type: COMPARATOR
Intervention: Group D (3.5 mL/s and 90 mAs)
Number of subjects: 119
Study 23530423 — intervention group
Group type: EXPERIMENTAL
Intervention: Palivizumab (synagis)
Number of subjects: 0
Study 19176684 — intervention group
Group type: EXPERIMENTAL
Intervention: rATG induction therapy
Number of subjects: 16
Study 17696229 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexrabeprazole 10 mg
Number of subjects: 50
Study 17696229 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole 20 mg
Number of subjects: 50
Study 17696229 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 15747040 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management group
Number of subjects: 202
Study 15747040 — intervention group
Group type: COMPARATOR
Intervention: Family doctor group
Number of subjects: 202
Study 12165717 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam as adjuvant therapy
Number of subjects: 0
Study 12165717 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 9707190 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with rtPA
Number of subjects: 100
Study 8542209 — intervention group
Group type: EXPERIMENTAL
Intervention: Stationary bicycling at home (exercise group)
Number of subjects: 71
Study 8542209 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 71
Study 2229464 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 99
Study 2229464 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurazepam 15 mg
Number of subjects: 99
Study 2229464 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 99
Study 2229464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study 433806 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 g nitrogen diet
Number of subjects: 6
Study 433806 — intervention group
Group type: COMPARATOR
Intervention: 12 g nitrogen diet
Number of subjects: 6
Study 433806 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet
Number of subjects: 6
Study 30944143 — intervention group
Group type: EXPERIMENTAL
Intervention: CONCERTO+ eHealth platform for chronic disease management, used for 6 months
Number of subjects: 0
Study 30944143 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study 29890150 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with concurrent thoracic radiotherapy (50 Gy) followed by resection and postoperative consolidation chemotherapy
Number of subjects: 40
Study 26389979 — intervention group
Group type: EXPERIMENTAL
Intervention: ReadySteady intervention
Number of subjects: 30
Study 24650627 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory-based emotion regulation (ER) training focusing on expressive suppression
Number of subjects: 81
Study 24650627 — intervention group
Group type: EXPERIMENTAL
Intervention: Laboratory-based emotion regulation (ER) training focusing on cognitive reappraisal
Number of subjects: 81
Study 24650627 — intervention group
Group type: EXPERIMENTAL
Intervention: Binge eating disorder (BED) group
Number of subjects: 81
Study 24650627 — intervention group
Group type: COMPARATOR
Intervention: Overweight females without BED
Number of subjects: 81
Study 21087399 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading with fixed bridges (test group, n=9)
Number of subjects: 18
Study 21087399 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading (control group, n=9)
Number of subjects: 18
Study 19272623 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline treatment
Number of subjects: 20
Study 19272623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 19272623 — intervention group
Group type: COMPARATOR
Intervention: Bicompartmental model
Number of subjects: 20
Study 19272623 — intervention group
Group type: COMPARATOR
Intervention: Monocompartmental model
Number of subjects: 20
Study 17785367 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat-low carbohydrate (HF-LC) diet (66% fat, 4% carbohydrate)
Number of subjects: 23
Study 17785367 — intervention group
Group type: COMPARATOR
Intervention: Moderate fat-moderate carbohydrate (MF-MC) diet (35% fat, 35% carbohydrate)
Number of subjects: 23
Study 17785367 — intervention group
Group type: EXPERIMENTAL
Intervention: High fat-low carbohydrate (HF-LC) diet
Number of subjects: 23
Study 17785367 — intervention group
Group type: COMPARATOR
Intervention: Moderate fat-moderate carbohydrate (MF-MC) diet
Number of subjects: 23
Study 15185765 — intervention group
Group type: EXPERIMENTAL
Intervention: EC‐IC bypass with risk factor modifications
Number of subjects: 0
Study 15185765 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical group
Number of subjects: 0
Study 15185765 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical group
Number of subjects: 0
Study 11453955 — intervention group
Group type: EXPERIMENTAL
Intervention: GH administration (1.80 +/- 0.24 IU/day) for 12 weeks
Number of subjects: 16
Study 11453955 — intervention group
Group type: EXPERIMENTAL
Intervention: GH administration
Number of subjects: 16
Study 11453955 — intervention group
Group type: EXPERIMENTAL
Intervention: GH discontinuation
Number of subjects: 16
Study 11453955 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 16
Study 9483598 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol with nitrous oxide (70%)
Number of subjects: 60
Study 9483598 — intervention group
Group type: COMPARATOR
Intervention: Propofol without nitrous oxide (O2)
Number of subjects: 60
Study 9483598 — intervention group
Group type: COMPARATOR
Intervention: Halothane/nitrous oxide (70%)
Number of subjects: 60
Study 8304304 — intervention group
Group type: EXPERIMENTAL
Intervention: H. pylori infection present
Number of subjects: 181
Study 2656134 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 31
Study 2656134 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 31
Study 5413950 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergotamine tartrate (0.25 mg. intravenously)
Number of subjects: 0
Study 5413950 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergometrine maleate (0.25 mg. intravenously)
Number of subjects: 0
Study 28436015 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% topical minoxidil solution applied twice daily to fingernails
Number of subjects: 32
Study 28436015 — intervention group
Group type: COMPARATOR
Intervention: Untreated nails
Number of subjects: 32
Study 25752476 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Replacement (TAVR)
Number of subjects: 0
Study 25752476 — intervention group
Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 0
Study 25752476 — intervention group
Group type: COMPARATOR
Intervention: Surgical Aortic Valve Replacement
Number of subjects: 0
Study 22999803 — intervention group
Group type: EXPERIMENTAL
Intervention: CPD planning worksheets (test group)
Number of subjects: 105
Study 22999803 — intervention group
Group type: COMPARATOR
Intervention: No specific intervention (control group)
Number of subjects: 105
Study 22089302 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 80% maximal intensity for 20 min
Number of subjects: 14
Study 22089302 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 60% maximal intensity for 40 min
Number of subjects: 14
Study 19023932 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS monitoring group (n = 78)
Number of subjects: 156
Study 19023932 — intervention group
Group type: COMPARATOR
Intervention: No-BIS monitoring group (n = 78)
Number of subjects: 156
Study 16467096 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2 (10‐minute i.v. infusion) on day 1 of a 21‐day cycle with folic acid and vitamin B12 supplementation
Number of subjects: 61
Study 16467096 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m2
Number of subjects: 61
Study 16467096 — intervention group
Group type: EXPERIMENTAL
Intervention: Pemetrexed chemotherapy
Number of subjects: 61
Study 12620606 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (mu-opioid agonist) administered via computer-controlled infusion targeting plasma concentrations between 0 and 6 ng/ml.
Number of subjects: 12
Study 12620606 — intervention group
Group type: COMPARATOR
Intervention: Freezing the skin (experimental model of hyperalgesia).
Number of subjects: 12
Study 17118044 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus consultations with a specialist prenatal care nurse
Number of subjects: 284
Study 17118044 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus nurse consultations and a home visitor
Number of subjects: 284
Study 17118044 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 284
Study 10490109 — intervention group
Group type: EXPERIMENTAL
Intervention: 585-nm flashlamp-pumped pulsed-dye laser
Number of subjects: 20
Study 10490109 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone gel sheeting
Number of subjects: 20
Study 10490109 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated sections)
Number of subjects: 20
Study 8744657 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (2 mg loading dose, 0.5 mg boluses, 0.2 mg/h infusion)
Number of subjects: 30
Study 8744657 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl (60 micrograms loading dose, 25 micrograms boluses)
Number of subjects: 30
Study 8744657 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl plus morphine (F/M group)
Number of subjects: 30
Study 1743226 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravesical mitomycin C (MMC)
Number of subjects: 91
Study 1743226 — intervention group
Group type: COMPARATOR
Intervention: Bacillus Calmette‐Guérin (BCG)
Number of subjects: 91
Study 7020108 — intervention group
Group type: EXPERIMENTAL
Intervention: Penbutolol 40 mg daily for 7 days
Number of subjects: 0
Study 7020108 — intervention group
Group type: COMPARATOR
Intervention: Penbutolol 4 mg intravenous
Number of subjects: 0
Study 31524123 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid-based nutrient supplements (LNS)
Number of subjects: 375
Study 31524123 — intervention group
Group type: COMPARATOR
Intervention: Non-LNS (multiple micronutrients (MMN) + iron and folic acid (IFA))
Number of subjects: 375
Study 27879499 — intervention group
Group type: EXPERIMENTAL
Intervention: MFCL N (center-near)
Number of subjects: 17
Study 27879499 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal
Number of subjects: 17
Study 27879499 — intervention group
Group type: EXPERIMENTAL
Intervention: MFCL D (center-distance)
Number of subjects: 17
Study 27879499 — intervention group
Group type: COMPARATOR
Intervention: Control (single vision)
Number of subjects: 17
Study 25665004 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable Plyometric Training (SPT)
Number of subjects: 24
Study 25665004 — intervention group
Group type: COMPARATOR
Intervention: Highly Unstable Plyometric Training (IPT)
Number of subjects: 24
Study 24893708 — intervention group
Group type: COMPARATOR
Intervention: 40 mg atomoxetine
Number of subjects: 25
Study 22956850 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal Noise (ON)
Number of subjects: 8
Study 22956850 — intervention group
Group type: COMPARATOR
Intervention: Zero Noise (ZN)
Number of subjects: 8
Study 22956850 — intervention group
Group type: COMPARATOR
Intervention: High Noise (HN)
Number of subjects: 8
Study 19236162 — intervention group
Group type: EXPERIMENTAL
Intervention: LC1 (pseudomanic behavior)
Number of subjects: 252
Study 19236162 — intervention group
Group type: EXPERIMENTAL
Intervention: LC2 (cognitive)
Number of subjects: 252
Study 19236162 — intervention group
Group type: COMPARATOR
Intervention: LC3 (pseudodepressed behavior)
Number of subjects: 252
Study 17170019 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise (DE) counselling group intervention
Number of subjects: 2022
Study 15325894 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy done twice by a single examiner
Number of subjects: 14
Study 15325894 — intervention group
Group type: EXPERIMENTAL
Intervention: AviScope examination
Number of subjects: 14
Study 15325894 — intervention group
Group type: COMPARATOR
Intervention: Naked eye inspection
Number of subjects: 14
Study 15325894 — intervention group
Group type: EXPERIMENTAL
Intervention: Colposcopy done by two examiners
Number of subjects: 14
Study 11795343 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/day of tamoxifen
Number of subjects: 5408
Study 11795343 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5408
Study 9625100 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg Ca as calcium carbonate twice daily with meals for 6 months
Number of subjects: 187
Study 9625100 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily with meals for 6 months
Number of subjects: 187
Study 9625100 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactating women
Number of subjects: 187
Study 9625100 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactating women after weaning
Number of subjects: 187
Study 9625100 — intervention group
Group type: EXPERIMENTAL
Intervention: Women previously lactating
Number of subjects: 187
Study 8043313 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous pyridoxine (1 g dose)
Number of subjects: 108
Study 8043313 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 108
Study 31556668 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced counseling for pain coping skills
Number of subjects: 148
Study 31556668 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling
Number of subjects: 148
Study 28437795 — intervention group
Group type: EXPERIMENTAL
Intervention: HEART care
Number of subjects: 3648
Study 28437795 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3648
Study 26700304 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Number of subjects: 0
Study 26700304 — intervention group
Group type: COMPARATOR
Intervention: Best supportive care
Number of subjects: 0
Study 23343224 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen for 2 years
Number of subjects: 564
Study 23343224 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant systemic treatment
Number of subjects: 564
Study 21605000 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (n = 26)
Number of subjects: 97
Study 21605000 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose flutamide-metformin plus an oral contraceptive (PCOS women, n = 58)
Number of subjects: 97
Study 21605000 — intervention group
Group type: COMPARATOR
Intervention: Untreated (n = 13)
Number of subjects: 97
Study 21605000 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 97
Study 18447762 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention by drug consultation center (DCC) - information by phone, mailed written form, and text messages
Number of subjects: 108
Study 18447762 — intervention group
Group type: COMPARATOR
Intervention: Control group - information given once
Number of subjects: 108
Study 18447762 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study 16487434 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (50 mg p.o. daily at bedtime)
Number of subjects: 24
Study 14509058 — intervention group
Group type: EXPERIMENTAL
Intervention: verum-rTMS
Number of subjects: 11
Study 14509058 — intervention group
Group type: COMPARATOR
Intervention: placebo-rTMS
Number of subjects: 11
Study 10881815 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibroblast growth factor injected directly into the myocardium, close to the left anterior descending coronary artery.
Number of subjects: 40
Study 10881815 — intervention group
Group type: COMPARATOR
Intervention: Heat denatured fibroblast growth factor injected into the myocardium.
Number of subjects: 40
Study 9361332 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg haloperidol (i.v.)
Number of subjects: 0
Study 9361332 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg haloperidol (i.v.)
Number of subjects: 0
Study 8248606 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 33
Study 8248606 — intervention group
Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 33
Study 8248606 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 33
Study 8248606 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Fentanyl, Halothane, Isoflurane)
Number of subjects: 33
Study 3513472 — intervention group
Group type: EXPERIMENTAL
Intervention: Open biopsy of non-palpable breast lesions
Number of subjects: 314
Study 31706728 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing training intervention during hospitalisation
Number of subjects: 366
Study 31706728 — intervention group
Group type: COMPARATOR
Intervention: Habitual performance (control group)
Number of subjects: 366
Study 30594122 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg
Number of subjects: 2886
Study 30594122 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 240 mg
Number of subjects: 2886
Study 30594122 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2886
Study 27554378 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Oral Anticoagulants (DOACs)
Number of subjects: 51
Study 27554378 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K Antagonists (VKAs)
Number of subjects: 51
Study 23619813 — intervention group
Group type: EXPERIMENTAL
Intervention: Bluetooth headset EMFs
Number of subjects: 12
Study 23619813 — intervention group
Group type: COMPARATOR
Intervention: Mobile phone EMFs
Number of subjects: 12